|Articles|August 5, 2014
Venn Life Sciences Acquires French CRO
Venn Life Sciences announced the acquisition of Cardinal Systems SAS
Advertisement
Venn Life Sciences, a CRO based in Europe, announced the acquisition of Cardinal Systems SAS, a France based CRO specializing in data management and randomization systems. The acquisition extends Venn’s service offering into those two areas, and strengthens the company’s position as a full-service European CRO.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV
2
When AI Learns to Speak Every Language: An eCOA Migration Study
3
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
4
Using Digital Tools to Enhance Patient-Centric Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
